• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

G 蛋白偶联受体的变构反向激动剂抗体失活。

G-protein-coupled receptor inactivation by an allosteric inverse-agonist antibody.

机构信息

Iwata Human Receptor Crystallography Project, ERATO, Japan Science and Technology Agency, Yoshidakonoe-cho, Sakyo-ku, Kyoto 606-8501, Japan.

出版信息

Nature. 2012 Jan 29;482(7384):237-40. doi: 10.1038/nature10750.

DOI:10.1038/nature10750
PMID:22286059
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3303121/
Abstract

G-protein-coupled receptors are the largest class of cell-surface receptors, and these membrane proteins exist in equilibrium between inactive and active states. Conformational changes induced by extracellular ligands binding to G-protein-coupled receptors result in a cellular response through the activation of G proteins. The A(2A) adenosine receptor (A(2A)AR) is responsible for regulating blood flow to the cardiac muscle and is important in the regulation of glutamate and dopamine release in the brain. Here we report the raising of a mouse monoclonal antibody against human A(2A)AR that prevents agonist but not antagonist binding to the extracellular ligand-binding pocket, and describe the structure of A(2A)AR in complex with the antibody Fab fragment (Fab2838). This structure reveals that Fab2838 recognizes the intracellular surface of A(2A)AR and that its complementarity-determining region, CDR-H3, penetrates into the receptor. CDR-H3 is located in a similar position to the G-protein carboxy-terminal fragment in the active opsin structure and to CDR-3 of the nanobody in the active β(2)-adrenergic receptor structure, but locks A(2A)AR in an inactive conformation. These results suggest a new strategy to modulate the activity of G-protein-coupled receptors.

摘要

G 蛋白偶联受体是细胞表面受体中最大的一类,这些膜蛋白在非活性和活性状态之间处于平衡状态。细胞外配体与 G 蛋白偶联受体结合诱导的构象变化通过激活 G 蛋白导致细胞反应。A(2A) 腺苷受体 (A(2A)AR) 负责调节心肌的血流量,并且在大脑中调节谷氨酸和多巴胺的释放中很重要。在这里,我们报告了一种针对人 A(2A)AR 的小鼠单克隆抗体的产生,该抗体可防止激动剂但不阻止拮抗剂与细胞外配体结合口袋结合,并描述了 A(2A)AR 与抗体 Fab 片段 (Fab2838) 复合物的结构。该结构表明 Fab2838 识别 A(2A)AR 的细胞内表面,并且其互补决定区 CDR-H3 穿透到受体中。CDR-H3 位于与活性视蛋白结构中的 G 蛋白羧基末端片段和活性β(2)-肾上腺素能受体结构中的纳米体 CDR-3 相似的位置,但将 A(2A)AR 锁定在非活性构象中。这些结果表明了一种调节 G 蛋白偶联受体活性的新策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f9f/3303121/80d141af58f7/ukmss-40157-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f9f/3303121/a4d9604fe73c/ukmss-40157-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f9f/3303121/b9df8b11ae1a/ukmss-40157-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f9f/3303121/80d141af58f7/ukmss-40157-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f9f/3303121/a4d9604fe73c/ukmss-40157-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f9f/3303121/b9df8b11ae1a/ukmss-40157-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f9f/3303121/80d141af58f7/ukmss-40157-f0003.jpg

相似文献

1
G-protein-coupled receptor inactivation by an allosteric inverse-agonist antibody.G 蛋白偶联受体的变构反向激动剂抗体失活。
Nature. 2012 Jan 29;482(7384):237-40. doi: 10.1038/nature10750.
2
Activation of the A2A adenosine G-protein-coupled receptor by conformational selection.通过构象选择激活 A2A 腺苷 G 蛋白偶联受体。
Nature. 2016 May 12;533(7602):265-8. doi: 10.1038/nature17668. Epub 2016 May 4.
3
Structure of an agonist-bound human A2A adenosine receptor.激动剂结合的人 A2A 腺苷受体结构。
Science. 2011 Apr 15;332(6027):322-7. doi: 10.1126/science.1202793. Epub 2011 Mar 10.
4
Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation.激动剂结合的腺苷 A2A 受体结构揭示了 G 蛋白偶联受体激活的共同特征。
Nature. 2011 May 18;474(7352):521-5. doi: 10.1038/nature10136.
5
Integrating Pharmacophore into Membrane Molecular Dynamics Simulations to Improve Homology Modeling of G Protein-coupled Receptors with Ligand Selectivity: A2A Adenosine Receptor as an Example.将药效团整合到膜分子动力学模拟中以改善具有配体选择性的G蛋白偶联受体的同源建模:以A2A腺苷受体为例
Chem Biol Drug Des. 2015 Dec;86(6):1438-50. doi: 10.1111/cbdd.12607. Epub 2015 Jul 14.
6
Structural insights into agonist-induced activation of G-protein-coupled receptors.激动剂诱导 G 蛋白偶联受体激活的结构见解。
Curr Opin Struct Biol. 2011 Aug;21(4):541-51. doi: 10.1016/j.sbi.2011.06.002. Epub 2011 Jun 30.
7
Allosteric nanobodies reveal the dynamic range and diverse mechanisms of G-protein-coupled receptor activation.变构纳米抗体揭示了G蛋白偶联受体激活的动态范围和多种机制。
Nature. 2016 Jul 21;535(7612):448-52. doi: 10.1038/nature18636. Epub 2016 Jul 13.
8
Evaluation of homology modeling of G-protein-coupled receptors in light of the A(2A) adenosine receptor crystallographic structure.基于A(2A)腺苷受体晶体结构对G蛋白偶联受体同源建模的评估。
J Med Chem. 2009 May 28;52(10):3284-92. doi: 10.1021/jm801533x.
9
Structure of a nanobody-stabilized active state of the β(2) adrenoceptor.β2 肾上腺素能受体的纳米体稳定的活性状态结构。
Nature. 2011 Jan 13;469(7329):175-80. doi: 10.1038/nature09648.
10
Dynamic Role of the G Protein in Stabilizing the Active State of the Adenosine A Receptor.G 蛋白在稳定腺苷 A 受体活性状态中的动态作用。
Structure. 2019 Apr 2;27(4):703-712.e3. doi: 10.1016/j.str.2018.12.007. Epub 2019 Jan 31.

引用本文的文献

1
Structural basis of anticancer drug recognition and amino acid transport by LAT1.LAT1识别抗癌药物及转运氨基酸的结构基础
Nat Commun. 2025 Feb 14;16(1):1635. doi: 10.1038/s41467-025-56903-w.
2
G Protein-Coupled Receptor-Ligand Pose and Functional Class Prediction.G 蛋白偶联受体-配体构象和功能分类预测。
Int J Mol Sci. 2024 Jun 22;25(13):6876. doi: 10.3390/ijms25136876.
3
Computational design of soluble and functional membrane protein analogues.可溶性和功能型膜蛋白类似物的计算设计。

本文引用的文献

1
Conformational changes in the G protein Gs induced by the β2 adrenergic receptor.β2 肾上腺素受体诱导 G 蛋白 Gs 的构象变化。
Nature. 2011 Sep 28;477(7366):611-5. doi: 10.1038/nature10488.
2
Structure of the adenosine A(2A) receptor in complex with ZM241385 and the xanthines XAC and caffeine.腺苷 A(2A)受体与 ZM241385、黄嘌呤衍生物 XAC 和咖啡因复合物的结构。
Structure. 2011 Sep 7;19(9):1283-93. doi: 10.1016/j.str.2011.06.014.
3
Crystal structure of the β2 adrenergic receptor-Gs protein complex.β2 肾上腺素能受体-Gs 蛋白复合物的晶体结构。
Nature. 2024 Jul;631(8020):449-458. doi: 10.1038/s41586-024-07601-y. Epub 2024 Jun 19.
4
Exploring GPCR conformational dynamics using single-molecule fluorescence.利用单分子荧光技术探索 G 蛋白偶联受体构象动力学。
Methods. 2024 Jun;226:35-48. doi: 10.1016/j.ymeth.2024.03.011. Epub 2024 Apr 10.
5
Current achievements, strategies, obstacles, and overcoming the challenges of the protein engineering in Pichia pastoris expression system.毕赤酵母表达系统中蛋白质工程的当前成就、策略、障碍及挑战应对
World J Microbiol Biotechnol. 2023 Dec 8;40(1):39. doi: 10.1007/s11274-023-03851-6.
6
Anti-nanodisc antibodies specifically capture nanodiscs and facilitate molecular interaction kinetics studies for membrane protein.抗纳米盘抗体特异性捕获纳米盘,并促进膜蛋白的分子相互作用动力学研究。
Sci Rep. 2023 Jul 19;13(1):11627. doi: 10.1038/s41598-023-38547-2.
7
Yeast Heterologous Expression Systems for the Study of Plant Membrane Proteins.酵母异源表达系统在植物膜蛋白研究中的应用。
Int J Mol Sci. 2023 Jun 28;24(13):10768. doi: 10.3390/ijms241310768.
8
Crystal structure of adenosine A receptor in complex with clinical candidate Etrumadenant reveals unprecedented antagonist interaction.与临床候选药物Etrumadenant结合的腺苷A受体的晶体结构揭示了前所未有的拮抗剂相互作用。
Commun Chem. 2023 Jun 1;6(1):106. doi: 10.1038/s42004-023-00894-6.
9
New insights into GPCR coupling and dimerisation from cryo-EM structures.冷冻电镜结构揭示 G 蛋白偶联受体的偶联和二聚化新机制
Curr Opin Struct Biol. 2023 Jun;80:102574. doi: 10.1016/j.sbi.2023.102574. Epub 2023 Mar 22.
10
Systematic analyses of the sequence conservation and ligand interaction patterns of purinergic P1 and P2Y receptors provide a structural basis for receptor selectivity.对嘌呤能P1和P2Y受体的序列保守性和配体相互作用模式进行系统分析,为受体选择性提供了结构基础。
Comput Struct Biotechnol J. 2023 Jan 10;21:889-898. doi: 10.1016/j.csbj.2023.01.010. eCollection 2023.
Nature. 2011 Jul 19;477(7366):549-55. doi: 10.1038/nature10361.
4
Structure of the human histamine H1 receptor complex with doxepin.人源组胺 H1 受体复合物与多塞平的结构。
Nature. 2011 Jun 22;475(7354):65-70. doi: 10.1038/nature10236.
5
Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation.激动剂结合的腺苷 A2A 受体结构揭示了 G 蛋白偶联受体激活的共同特征。
Nature. 2011 May 18;474(7352):521-5. doi: 10.1038/nature10136.
6
Structure of an agonist-bound human A2A adenosine receptor.激动剂结合的人 A2A 腺苷受体结构。
Science. 2011 Apr 15;332(6027):322-7. doi: 10.1126/science.1202793. Epub 2011 Mar 10.
7
The structural basis for agonist and partial agonist action on a β(1)-adrenergic receptor.激动剂和部分激动剂在β(1)-肾上腺素能受体上作用的结构基础。
Nature. 2011 Jan 13;469(7329):241-4. doi: 10.1038/nature09746.
8
Structure and function of an irreversible agonist-β(2) adrenoceptor complex.不可逆激动剂-β(2)肾上腺素能受体复合物的结构与功能。
Nature. 2011 Jan 13;469(7329):236-40. doi: 10.1038/nature09665.
9
Structure of a nanobody-stabilized active state of the β(2) adrenoceptor.β2 肾上腺素能受体的纳米体稳定的活性状态结构。
Nature. 2011 Jan 13;469(7329):175-80. doi: 10.1038/nature09648.
10
Recent developments in adenosine receptor ligands and their potential as novel drugs.腺苷受体配体的最新进展及其作为新型药物的潜力。
Biochim Biophys Acta. 2011 May;1808(5):1290-308. doi: 10.1016/j.bbamem.2010.12.017. Epub 2010 Dec 23.